Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | CD19-CD34 CAR transduced T-cells |
| Trade Name | |
| Synonyms | CD19-CD34t Metabolically Programmed CAR T-cells |
| Drug Descriptions |
CD19-CD34 CAR transduced T-cells are metabolically enhanced T lymphocytes engineered to express a chimeric antigen receptor (CAR) targeting CD19 and selected for CD34 expression, which potentially induce toxicity in CD19-expressing tumor cells (NCI Drug Dictionary). |
| DrugClasses | CD19 Immune Cell Therapy 72 |
| CAS Registry Number | NA |
| NCIT ID | C202931 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| CD19-CD34 CAR transduced T-cells | CD19-CD34 CAR transduced T-cells | 0 | 1 |
| CD19-CD34 CAR transduced T-cells + Cyclophosphamide + Fludarabine | CD19-CD34 CAR transduced T-cells Cyclophosphamide Fludarabine | 0 | 1 |